Exactly ,no arguments here, big companies don,t make money by pouring it down the drain, they quite effectively lose it by doing so and big companies do pour money down the drain ask bhp and rio.
If we ate discussing BIG companies (Huge Even) then ask Takeda why they felt the need to obtain a license agreement via Tigenix with Mesoblast folliwed by a takeover.
All I'm saying is don't dismiss a company
just because it doesn't have revenue.
Mesenchymal cells are emerging from a period of research and late stage trials are only now reaching efficacy after proving safety over many years.
KEEP WATCH
Mesoblast has turned a corner, page-837
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.055(4.66%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $4.824M | 4.236M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25589 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |